Nothing Special   »   [go: up one dir, main page]

Suh et al., 2018 - Google Patents

Common biological mechanisms of alcohol use disorder and post-traumatic stress disorder

Suh et al., 2018

View HTML
Document ID
1577424625247799758
Author
Suh J
Ressler K
Publication year
Publication venue
Alcohol research: current reviews

External Links

Snippet

Post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) are highly comorbid. Although recent clinical studies provide some understanding of biological and subsequent behavioral changes that define each of these disorders, the neurobiological basis of …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Suh et al. Common biological mechanisms of alcohol use disorder and post-traumatic stress disorder
Bredewold et al. Sex differences in the regulation of social and anxiety-related behaviors: insights from vasopressin and oxytocin brain systems
Huang et al. Chronic and acute intranasal oxytocin produce divergent social effects in mice
Jovanovic et al. How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD
Sharp Basolateral amygdala and stress-induced hyperexcitability affect motivated behaviors and addiction
Buisman-Pijlman et al. Individual differences underlying susceptibility to addiction: Role for the endogenous oxytocin system
Hart et al. Neuroimaging of child abuse: a critical review
McEwen et al. Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease
Egli et al. Alcohol dependence as a chronic pain disorder
Heim et al. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies
De Bellis et al. Neurodevelopmental biology associated with childhood sexual abuse
Bakermans-Kranenburg et al. Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy
Lipska Using animal models to test a neurodevelopmental hypothesis of schizophrenia
Tottenham et al. A review of adversity, the amygdala and the hippocampus: a consideration of developmental timing
Clark et al. The brain and behavior: an introduction to behavioral neuroanatomy
Gottschalk et al. Oxytocin and anxiety disorders
Kompier et al. Early life adversity and adult social behavior: focus on arginine vasopressin and oxytocin as potential mediators
Schümann et al. Dissociation of immediate and delayed effects of emotional arousal on episodic memory
Modi et al. A unified circuit for social behavior
Ago et al. Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist
Charney The psychobiology of resilience and vulnerability to anxiety disorders: implications for prevention and treatment
Malik et al. Understanding translational research in schizophrenia: a novel insight into animal models
Pérez-Ramírez et al. Brain network allostasis after chronic alcohol drinking is characterized by functional dedifferentiation and narrowing
Xu et al. Genetic modulation of plasma NPY stress response is suppressed in substance abuse: association with clinical outcomes
Malanga et al. Prenatal exposure to cocaine increases the rewarding potency of cocaine and selective dopaminergic agonists in adult mice